Ovarian cancer stage IV – Diagnostics

Go back

Stage IV ovarian cancer means that cancer which started in the ovaries, fallopian tubes, or the abdominal lining has now traveled to distant parts of the body, such as the lungs, liver, or other organs. Diagnosing this advanced stage involves a combination of physical examinations, imaging scans, blood tests, and surgical procedures to confirm where the cancer has spread and help doctors plan the best possible treatment approach.

Introduction: Who Should Seek Diagnostics for Stage IV Ovarian Cancer

Stage IV ovarian cancer is diagnosed when cancer cells have moved beyond the pelvis and abdomen to reach distant areas of the body. Women who experience persistent symptoms that don’t go away or that worsen over time should consider seeking medical evaluation. These symptoms can be subtle and easy to overlook, which is why many cases are not discovered until the disease has already progressed to a more advanced stage.[1]

Common warning signs include feeling full even after eating only a small amount of food, unexplained weight loss, ongoing digestive problems like constipation or diarrhea, pain or bloating in the belly area, frequent urination, persistent tiredness, and lower back pain. Some women also experience shortness of breath, especially if fluid builds up around the lungs.[2][8] Because these symptoms can also be caused by many other common health issues, it’s important to pay attention if they continue for a long time or get worse.

If you have a family history of ovarian or breast cancer, have inherited genetic mutations such as BRCA1 or BRCA2, or have conditions like endometriosis (a condition where tissue similar to the lining of the uterus grows outside it), you may be at higher risk. Women over the age of 60, those who are obese, or those who have never been pregnant are also more vulnerable.[5] Regular check-ups and open conversations with your doctor about any concerning symptoms can help ensure that necessary diagnostic tests are done without delay.

Even though there is currently no successful screening test for ovarian cancer that can catch it early in all women, being aware of your body and acting on persistent symptoms can make a significant difference. If your primary care doctor or gynecologist suspects ovarian cancer based on your symptoms and physical examination, they will refer you for further diagnostic testing to understand the extent of the disease.[5]

⚠️ Important
Ovarian cancer is often called a “silent” disease because symptoms in the early stages may not be noticeable. By the time clear symptoms appear, the cancer may have already spread. This is why more than 75% of people with ovarian cancer are diagnosed at an advanced stage. If you notice symptoms that persist or worsen, do not delay in seeking medical advice, even if they seem minor.[8]

Classic Diagnostic Methods for Stage IV Ovarian Cancer

Diagnosing stage IV ovarian cancer involves several steps and different types of tests. Because the exact stage of cancer often cannot be determined until surgery is performed, doctors use a combination of physical exams, imaging tests, blood tests, and surgical procedures to gather as much information as possible.[1][7]

Physical Examination

The first step in diagnosis is usually a pelvic exam. During this exam, the doctor inserts gloved fingers into the vagina while pressing down on the abdomen at the same time. This allows them to feel the size, shape, and position of the ovaries and other pelvic organs. They also visually examine the external genitals, vagina, and cervix. If the ovaries feel enlarged or if there are any abnormal growths, the doctor will recommend further testing.[5][11]

Imaging Tests

Imaging tests are essential for seeing what is happening inside the body without surgery. These tests help doctors understand the size of tumors, where they are located, and whether cancer has spread to other organs.

Pelvic ultrasound is often one of the first imaging tests performed. This test uses sound waves to create pictures of the ovaries and surrounding structures. A special type of ultrasound called a transvaginal ultrasound involves inserting a small probe into the vagina to get a closer look at the ovaries.[5]

CT scans (computed tomography) use X-rays and computer technology to create detailed cross-sectional images of the abdomen and pelvis. CT scans are helpful for seeing if cancer has spread to other areas such as the liver, lungs, or lymph nodes.[5][11]

MRI scans (magnetic resonance imaging) use magnets and radio waves to produce detailed images of soft tissues. MRI may be used to get a clearer picture of certain organs and structures, especially if the CT scan results are unclear.[5]

PET scans (positron emission tomography) involve injecting a small amount of radioactive sugar into the body. Cancer cells absorb more of this sugar than normal cells, which makes them light up on the scan. PET scans can help identify areas of cancer that might not show up well on other imaging tests.[5]

Blood Tests

Blood tests can provide important clues about whether cancer is present. One of the most commonly used blood tests for ovarian cancer measures a substance called CA-125. CA-125 is a protein that is often found at high levels in the blood of women with ovarian cancer. However, it’s important to know that CA-125 levels can be normal even when cancer is present, and they can also be elevated in other conditions that are not cancer, such as endometriosis or infections. For this reason, doctors use CA-125 results in combination with other tests, not on its own.[5][11]

Blood tests may also check how well the organs are functioning, such as the liver and kidneys. This information helps doctors understand the patient’s overall health and plan treatment accordingly.[11]

Surgical Staging and Biopsy

The most definitive way to diagnose ovarian cancer and determine its stage is through surgery. During a surgical procedure, the doctor removes the ovaries and takes tissue samples from different areas of the pelvis and abdomen. These tissue samples are examined under a microscope by a specialist called a pathologist to confirm whether cancer cells are present and what type of cancer it is. This process is called pathological staging or surgical staging.[3][11]

Doctors also rinse the abdomen with salt water during surgery and collect the fluid to check for cancer cells. This fluid sample is called pelvic washings. The surgeon will examine the lymph nodes and other organs to see if cancer has spread. If cancer is found in distant organs like the liver or lungs, or if there is fluid around the lungs that contains cancer cells, it confirms that the cancer is stage IV.[1][9]

Sometimes, if a woman is too sick for major surgery or if the cancer has spread very widely, the doctor may perform a smaller procedure called a laparoscopy. During laparoscopy, a thin tube with a camera is inserted through a small cut in the abdomen to look inside and take tissue samples. This can help confirm the diagnosis without the need for a large operation.[5]

Understanding Stage IV Subtypes

Stage IV ovarian cancer is divided into two subtypes. Stage IVa means that cancer has caused a buildup of fluid in the lining of the lungs, called a malignant pleural effusion. This fluid contains cancer cells.[1][9]

Stage IVb means that cancer has spread to the inside of distant organs such as the liver or spleen, or to lymph nodes outside the abdomen, or to other organs like the lungs or bones.[1][9]

Determining which subtype is present helps doctors understand the extent of the disease and guides treatment decisions.

⚠️ Important
Doctors use the FIGO (International Federation of Gynecology and Obstetrics) staging system to classify ovarian cancer into stages 1 through 4. Another system called the TNM (tumor, node, metastases) system is also used. Both systems describe how much cancer is in the body and where it has spread. Your doctor may refer to either or both systems when explaining your diagnosis.[3][7]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or combinations of treatments to see if they work better than current options. For women with stage IV ovarian cancer, joining a clinical trial may provide access to cutting-edge therapies that are not yet widely available. However, to participate in a clinical trial, patients must meet certain criteria, and specific diagnostic tests are used to determine eligibility.[6]

Confirmation of Stage and Disease Extent

Before a patient can enroll in a clinical trial, doctors need to confirm the stage of cancer and understand exactly where and how much it has spread. This usually involves reviewing all previous imaging scans, blood test results, and surgical reports. Some trials may require additional or repeat imaging tests to get the most current picture of the disease.[3][12]

Genetic Testing

Many clinical trials for ovarian cancer now include genetic testing as part of the qualification process. Genetic testing looks at a sample of blood or tumor tissue to identify specific changes or mutations in genes. The most well-known mutations associated with ovarian cancer are in the BRCA1 and BRCA2 genes. Women with these mutations have a higher risk of developing ovarian and breast cancers.[11]

Knowing whether a patient has a BRCA mutation or other genetic changes can help doctors decide which clinical trial might be most suitable. Some trials test drugs that work specifically for patients with certain genetic mutations. For example, drugs called PARP inhibitors are often more effective in women whose tumors have BRCA mutations.[2][9]

Tissue Biopsy and Biomarker Testing

Clinical trials may require a fresh tissue sample from the tumor to test for specific markers or characteristics. This is called biomarker testing. Biomarkers are substances or traits found in cancer cells that can give information about how the cancer behaves and how it might respond to treatment. Testing for biomarkers helps match patients with trials that target those specific features.[12]

General Health and Organ Function Tests

Clinical trials often have strict requirements about the patient’s overall health. Doctors will check how well the heart, kidneys, liver, and other organs are working. This is done through blood tests, urine tests, and sometimes heart function tests like an electrocardiogram (ECG). These tests ensure that the patient is strong enough to tolerate the experimental treatment and that their organs can process and eliminate the drugs safely.[11][12]

Performance Status Assessment

A patient’s ability to perform daily activities is measured using a scale called performance status. This assessment considers how much the cancer affects daily life, such as the ability to walk, care for oneself, and work. Clinical trials often require patients to have a certain level of performance status, meaning they need to be well enough to participate safely.[12]

Prior Treatment History

Some clinical trials are designed for patients who have already received certain treatments, while others are for patients who have not yet been treated. Doctors will review the patient’s complete treatment history, including what surgeries have been done, what chemotherapy drugs have been used, and how the cancer responded to those treatments. This information determines whether the patient fits the specific criteria for a particular trial.[6][12]

Participating in a clinical trial can be an important option for women with stage IV ovarian cancer. Researchers are constantly working to improve treatments and find new ways to fight the disease. By undergoing the necessary diagnostic tests to qualify for a trial, patients may gain access to promising new therapies that could improve their outcomes and quality of life.[1][9]

Prognosis and Survival Rate

Prognosis

The prognosis for stage IV ovarian cancer depends on many individual factors, including the patient’s age, overall health, how well the cancer responds to treatment, and what treatment options are available. Because stage IV ovarian cancer has spread to distant parts of the body, it is more challenging to treat than earlier stages. However, treatment can often help control the disease, relieve symptoms, and improve quality of life. The goal of treatment may shift from trying to cure the cancer to managing it as a long-term condition and keeping patients as comfortable and healthy as possible for as long as possible.[2][8]

The amount of cancer remaining after surgery is an important factor affecting prognosis. Studies show that when surgeons are able to remove as much of the cancer as possible, patients tend to have better outcomes. However, the ability to remove all visible cancer depends on where the cancer has spread and the skill and experience of the surgical team. Some tumors are more accessible and easier to remove than others, which can influence survival.[12]

Patients with certain genetic mutations, such as BRCA1 or BRCA2, may respond better to specific treatments like PARP inhibitors. The type of ovarian cancer also matters. For example, different subtypes such as epithelial ovarian cancer, germ cell tumors, or stromal tumors have different behaviors and treatment responses.[6][11]

Survival Rate

Survival rates are statistics that estimate how many people with a certain type and stage of cancer will survive for a specific period of time, usually five years. It’s important to remember that these are averages based on large groups of people and do not predict what will happen to any individual patient. Many factors influence survival, and some patients live much longer than the average.[8]

For stage IV ovarian cancer overall, the five-year relative survival rate is approximately 30.3%. This means that, on average, about 30 out of 100 women diagnosed with stage IV ovarian cancer will be alive five years after their diagnosis, compared to women without cancer.[8]

However, survival rates vary depending on the specific type of ovarian cancer. For women initially diagnosed with stage IV germ cell tumors of the ovary, the five-year relative survival rate is about 71%. For ovarian stromal tumors at stage IV, it is about 70%. For invasive epithelial ovarian cancer, which is the most common type, the five-year relative survival rate for stage IV is about 31%.[2]

Some women with late-stage ovarian cancer respond very well to treatment and survive for many years. About 20% of those with advanced ovarian cancer live more than 12 years after treatment, and in medical terms, they may be considered cured.[24]

It’s also important to know that survival rates improve over time as new treatments and better care become available. The statistics are based on people diagnosed several years ago, so current patients may have better outcomes thanks to advances in medicine.[2][8]

Every patient’s situation is unique. Your doctor can provide a more personalized estimate based on your specific circumstances, including your overall health, the characteristics of your cancer, and how you respond to treatment. Open and honest conversations with your healthcare team can help you understand your prognosis and make informed decisions about your care.[2][24]

Ongoing Clinical Trials on Ovarian cancer stage IV

  • Study on Letrozole vs. Chemotherapy (Carboplatin and Paclitaxel) for Patients with Advanced Low-Grade Serous Ovarian Cancer with Hormone Receptors

    Recruiting

    3 1 1 1
    Czechia Italy
  • Study on Niraparib, Carboplatin, and Paclitaxel for Advanced Ovarian Cancer Patients After Tumor Removal

    Recruiting

    2 1 1 1
    Austria Belgium Czechia Germany Italy Spain
  • Study on Adjusting Chemotherapy with Carboplatin and Paclitaxel for Patients with Poor Prognostic Ovarian Cancer

    Recruiting

    3 1 1 1
    France Italy The Netherlands
  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium France Spain
  • Study on the Effects of Tinzaparin on Biomarkers in Advanced Ovarian Cancer Patients Receiving Chemotherapy

    Recruiting

    2 1 1 1
    Investigated drugs:
    Sweden
  • Study of Niraparib and Dostarlimab Combined with Platinum Therapy for Newly Diagnosed Stage III or IV Non-mucinous Epithelial Ovarian Cancer

    Not recruiting

    3 1 1
    Belgium Czechia Denmark Finland France Germany +7

References

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/stages-grades/stage-4

https://www.webmd.com/ovarian-cancer/stage-4-ovarian-cancer

https://ocrahope.org/for-patients/gynecologic-cancers/ovarian-cancer/ovarian-cancer-staging/

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iv-ovarian-epithelial-fallopian-tube-and-primary-peritoneal-cancer

https://my.clevelandclinic.org/health/diseases/4447-ovarian-cancer

https://www.myovariancancerteam.com/resources/stage-4-ovarian-cancer-explained

https://www.cancer.org/cancer/types/ovarian-cancer/detection-diagnosis-staging/staging.html

https://www.medicalnewstoday.com/articles/stage-4-ovarian-cancer

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/stages-grades/stage-4

https://www.cancer.org/cancer/types/ovarian-cancer/treating.html

https://www.mayoclinic.org/diseases-conditions/ovarian-cancer/diagnosis-treatment/drc-20375946

https://www.ncbi.nlm.nih.gov/books/NBK83843/

https://cancer.ca/en/cancer-information/cancer-types/ovarian/treatment/epithelial-ovarian-cancer

https://www.texasoncology.com/types-of-cancer/ovarian-cancer/stage-iv-ovarian-cancer

https://www.dana-farber.org/cancer-care/types/ovarian-cancer/treatment

https://www.mdanderson.org/cancerwise/ovarian-cancer-survivor–how-i-ve-managed-stage-iv-cancer-for-10-years.h00-159303045.html

https://www.mdanderson.org/cancerwise/ovarian-cancer-survivor–how-i-ve-managed-stage-iv-cancer-for-10-years.h00-159303045.html

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/stages-grades/stage-4

http://blog.dana-farber.org/insight/2013/07/living-with-stage-iv-ovarian-cancer/

https://cancerblog.mayoclinic.org/2023/10/04/life-after-ovarian-cancer-coping-with-side-effects-fear-of-recurrence-and-finding-support/

https://www.myovariancancerteam.com/resources/end-stage-ovarian-cancer-expectations-and-emotional-care

https://blog.virginiacancer.com/what-to-expect-after-completing-ovarian-cancer-treatment

https://www.cancer.org/cancer/types/ovarian-cancer/after-treatment.html

https://www.webmd.com/ovarian-cancer/ovarian-cancer-late-stage

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

How is stage IV ovarian cancer different from earlier stages?

Stage IV ovarian cancer means the cancer has spread from the ovaries to distant parts of the body, such as the lungs, liver, or other organs. In earlier stages, the cancer is still more confined to the ovaries or nearby areas in the pelvis and abdomen. Stage IV is the most advanced stage and is more difficult to treat, though treatment can still help manage symptoms and improve quality of life.[1][9]

Can stage IV ovarian cancer be diagnosed without surgery?

Imaging tests like CT scans, MRI, and PET scans, along with blood tests for CA-125, can provide strong evidence that ovarian cancer has spread to distant organs. However, the most definitive diagnosis and staging usually require surgery, where tissue samples are taken and examined under a microscope. In some cases, a smaller procedure called laparoscopy can be used if major surgery is not possible.[5][11]

What is the CA-125 test and is it accurate?

The CA-125 test measures a protein in the blood that is often elevated in women with ovarian cancer. However, it is not 100% accurate because CA-125 levels can be normal even when cancer is present, and they can also be high in other conditions like endometriosis or infections. Doctors use CA-125 results alongside other tests, not as the only diagnostic tool.[5][11]

Why is genetic testing important for stage IV ovarian cancer?

Genetic testing can identify mutations in genes like BRCA1 and BRCA2 that increase the risk of ovarian cancer. Knowing whether these mutations are present helps doctors choose the most effective treatments, such as PARP inhibitors, which work better in patients with BRCA mutations. It also helps determine eligibility for certain clinical trials.[11][2]

Can I participate in a clinical trial if I have stage IV ovarian cancer?

Yes, many clinical trials are designed specifically for patients with advanced ovarian cancer. To qualify, you will need to undergo specific diagnostic tests to confirm your stage, check your overall health, and sometimes test for genetic mutations or biomarkers. Your doctor can help you find trials that match your situation.[6][12]

🎯 Key Takeaways

  • Stage IV ovarian cancer is diagnosed when cancer has spread to distant organs like the lungs, liver, or bones, making it the most advanced stage.
  • Persistent symptoms like bloating, belly pain, feeling full quickly, and shortness of breath should never be ignored, especially in women over 60 or those with a family history of cancer.
  • Diagnostic methods include pelvic exams, imaging tests like CT and MRI scans, blood tests for CA-125, and surgical procedures to confirm the stage and collect tissue samples.
  • The CA-125 blood test is helpful but not perfect, as levels can be normal with cancer present or high without cancer, so it’s used alongside other tests.
  • Genetic testing for BRCA mutations and other biomarkers helps guide treatment decisions and determines eligibility for targeted therapies and clinical trials.
  • Clinical trial participation requires specific diagnostic tests to confirm stage, assess overall health, and identify genetic or tumor characteristics that match trial criteria.
  • The five-year survival rate for stage IV ovarian cancer varies by cancer type, with overall rates around 30%, but some women survive much longer with effective treatment.
  • More than 75% of ovarian cancers are diagnosed at advanced stages because early symptoms are subtle, highlighting the importance of paying attention to your body and seeking timely medical advice.